7th European Congress: Perspectives in Gynecologic Oncology

29. 1. 2010 - 30. 1. 2010, W Barcelona Hotel, Barcelona, Spain

Registrace

Friday 29 January 2010
13:00
Welcome and introduction
Peter Harper, MD, FRCP


Session I: Cervical Cancer
Moderator: Peter Harper, MD, FRCP

13:05
HPV vaccination and implications for cervical cancer screening
F. Xavier Bosch, MD

13:30
Debate The role of surgical staging in operable cervical cancer Favors
SLN: Speaker invited
Opposes SLN: Speaker invited

14:30
Targeted agents in cervical cancer: New drugs in the horizon
Speaker invited

14:55
Management of cervical cancer during pregnancy
Speaker invited

15:15
Break

Session II: Endometrial Cancer
Moderator: Stanley B. Kaye, MD

15:45
Debate Are there still indications for lymphadenectomy – and if so, who should receive it?
No indication: Henry C. Kitchener, MD
There is an indication: Andrea Mariani, MD

16:45
Adjuvant treatment of endometrial cancer
Ignace Vergote, MD, PhD

17:10
Update on the management of trophoblastic disease
Michael Seckl, PhD, FRCP

17:35
Sarcomas of the uterus
Frederic Amant, MD, PhD

18:00
Adjourn

Saturday 30 January 2010
Session III: Ovarian Neoplasm I
Moderator: Ignace Vergote, MD, PhD

9:00
Welcome and introduction

9:10
Debate This house believes that neoadjuvant therapy should become standard of care in ovarian cancer
Pro: Speaker invited
Con: Jacobus Pfi sterer, MD, PhD

10:10
Management of borderline tumors
Andreas du Bois, MD, PhD

10:35
Break

10:55
Management of hypersensitivity reactions to platinums and taxanes
Peter G. Harper, MD, FRCP
Keynote Address

11:20
Controversies in recurrent ovarian cancer: Role of CA125 and timing of 2nd-line chemotherapy
Gordon J.S. Rustin, MD, FRCP

11:50
Lunch

Session IV: Ovarian Neoplasm II
Moderator: Andreas du Bois, MD, PhD

13:30
Case presentation and expert discussion
Management of a 9 month relapse patient: Speaker invited
Platinum perspective: Eric Pujade-Lauraine, MD, PhD

14:30
Update on new treatment options in recurrent ovarian cancer
Stanley B. Kaye, MD

14:55
Selection of the right patients for surgery in recurrent ovarian cancer
Philipp Harter, MD

15:20
Closing remarks
Stanley B. Kaye, MD

15:25
Adjourn

Kontakt: meetings@imedex.com

Web: http://www.imedex....ements/a132-01.asp

  • Sdílejte na:
    • Facebook
    • Twitter
    • Del.icio.us
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live